Table 1.
Demographics and characteristics of cohort
| Group | Gout (n = 31) | Control (n = 18) |
| Age, median (min-max) (n) | 63 (31-86) (31) | 49 (26-73) (18) |
| Male Gender (n, %) | 26 (83.9) | 6 (33.3) |
| History of CAD (n, %) | 9 (29.0) | 2 (11.1) |
| Diabetes (n, %) | 15 (48.4) | 4 (22.2) |
| Ever Smoked (n, %) | 19/29 (65.5) | 0/11 (0.0) |
| Total Cholesterol, median (min-max) (n) | 165 (114-250) (25) | 192 (145-247) (11) |
| HDL, median (min-max) (n) | 43 (24-88) (25) | 61 (35-88) (11) |
| LDL, median (min-max) (n) | 99 (58-179.2) (25) | 110 (66-139) (11) |
| Hemoglobin A1C, median (min-max) (n) | 5.9 (5.0-10.5) (24) | 5.7 (5.2-11) (9) |
| Systolic BP, median (min-max) (n) | 138 (98-175) (29) | 126.5 (101-157) (12) |
| Diastolic BP, median (min-max) (n) | 80 (61-104) (29) | 79.5 (66-99) (12) |
| Serum urate, median (min-max) (n) | 6 1-13.5) (29) | 4.4 (3.2-4.5) (3) |
| Total MSU volume aorta, mm3 median (min-max) (n) | 43.9 (0-1113.5) (31) | 2.9 (0-219.4) (18) |
| MSU spots Aorta median (min-max) (n) | 20(0-739) (31) | 1.5(0-104) (18) |
CAD: Cardiovascular disease; MSU: Monosodium urate.